Journal of Chinese Integrative Medicine ›› 2010, Vol. 8 ›› Issue (4): 368-372.doi: 10.3736/jcim20100412
• Original Experimental Research • Previous Articles Next Articles
Yan Leia
, Wei Tiana, Lin-qun Zhub, Jing Yanga, Ke-ji Chena
| [1] |
Lazarous DF, Shou M, Stiber JA, Hodge E, Thirumurti V , Gonçalves L, Unger EF . Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: effect on myocardial angiogenesis[J]. Cardiovasc Res, 1999,44(2):294-302
doi: 10.1016/S0008-6363(99)00203-5 |
| [2] |
Lei Y, Gao Q, Chen KJ . Effects of extracts from Panax Notoginseng and Panax Ginseng fruit on vascular endothelial cell proliferation and migration in vitro[J]. Chin J Integr Med, 2008,14(1):37-41
doi: 10.1007/s11655-008-0037-0 |
| [3] | Tian W, Lei Y . Research progress of traditional Chinese medicine in therapeutic angiogenesis[J]. Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi, 2008,14(4):319-321 |
| 田伟, 雷燕 . 中医药在治疗性血管生成中的研究进展[J]. 中国中医基础医学杂志, 2008,14(4):319-321 | |
| [4] | Lei Y, Wang PL, Lin YL, Chen KJ . Danggui Buxue Decoction promotes angiogenesis in ischemic myocardium of aging rats with myocardial infarction[J]. Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi, 2005,11(12):892-894 |
| 雷燕, 王培利, 林燕林, 陈可冀 . 当归补血汤煎剂对实验性心肌梗死衰老大鼠缺血心肌的促血管生成作用[J]. 中国中医基础医学杂志, 2005,11(12):892-894 | |
| [5] | Liu Y, Liu LX . Recognition of the effects of ginseng[J]. Shi Zhen Guo Yi Guo Yao, 2006,17(2):289 |
| 刘郁, 刘连新 . 人参功效再认识[J]. 时珍国医国药, 2006,17(2):289 | |
| [6] | Zhang XP, Qi LL, Liu DR . Research status of the pharmacological effects of Radix Notoginseng and its effective components[J]. Yi Xue Yan Jiu Za Zhi, 2007,36(4):96-98 |
| 张喜平, 齐丽丽, 刘达人 . 三七及其有效成分的药理作用研究现状[J]. 医学研究杂志, 2007,36(4):96-98 | |
| [7] |
Ferrara N, Gerber HP , LeCouter J . The biology of VEGF and its receptors[J]. Nat Med, 2003,9(6):669-676
doi: 10.1038/nm0603-669 |
| [8] |
La DS, Belzile J, Bready JV, Coxon A , DeMelfi T, Doerr N, Estrada J, Flynn JC, Flynn SR, Graceffa RF . Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis[J]. J Med Chem, 2008,51(6):1695-1705
doi: 10.1021/jm701129j |
| [9] |
Weiss MM, Harmange JC, Polverino AJ, Bauer D, Berry L, Berry V, Borg G, Bready J, Chen D, Choquette D . Evaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor[J]. J Med Chem, 2008,51(6):1668-1680
doi: 10.1021/jm701098w |
| [10] | Brekken RA, Overholser JP, Stastny VA, Waltenberger J, Minna JD, Thorpe PE . Selective inhibition of vascular endothelial growth factor(VEGF) receptor 2(KDR/Flk 1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice[J]. Cancer Research, 2000,60(18):5117-5124 |
| [11] | Marioni G, Giacomelli L , D’Alessandro E, Staffiere C Guzzardo V, Staffieri A, Blamdamura S . Laryngeal carcinoma recurrence rate and disease-free interval are related to CD105 expression but not to vascular endothelial growth factor 2(Flk-1/Kdr) expression[J]. Anticancer Res, 2008,28(1B):551-557 |